The In Vitro Diagnostics Market Dynamics are being fundamentally reshaped by shifts in the end-user landscape, particularly the growing importance of Standalone Laboratories and the evolving functional relationship between Central Labs and Point-of-Care (PoC) settings. While Hospital Laboratories still account for the largest revenue share (around 42.52% in 2024) due to their role in acute...